Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20356-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#20356-1-AP, RRID:AB_10734319
- Product name
- TRIM2 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated TRIM2 antibody (Cat. #20356-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references OSMR coordinates a self-perpetuating circuit linking chemoresistance and neutrophil-driven immunosuppression in gastric cancer.
YTHDF3-TRIM2-P53 axis promotes malignant progression in uveal melanoma (UVM).
Integrated multi-omics analysis and functional validation reveal the role of TRIM2 as a potential novel biomarker in breast cancer.
TRIM2 promotes metabolic adaptation to glutamine deprivation via enhancement of CPT1A activity.
TRIM2 inhibits apoptosis by ubiquitinating BNIP3 to protect the intestine against ischemia-reperfusion injury in mice.
E3 ubiquitin ligase TRIM2 identified as a novel suppressor of CYP11B2 and aldosterone production.
Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis.
Divergent self-association properties of paralogous proteins TRIM2 and TRIM3 regulate their E3 ligase activity.
TRIM2 directly deubiquitinates and stabilizes Snail1 protein, mediating proliferation and metastasis of lung adenocarcinoma.
Wei D, Chen J, Bai F, Li D, Liu J, Dou H, Lei Y, Zhang Y, Zhang B, Pang Y, Cao C, Yang T, Han J, Cao T
Neoplasia (New York, N.Y.) 2026 Mar;73:101279
Neoplasia (New York, N.Y.) 2026 Mar;73:101279
YTHDF3-TRIM2-P53 axis promotes malignant progression in uveal melanoma (UVM).
Li H, Chen Y, Chen W, Li D, Hao R, Zhang W
Cellular signalling 2026 Mar;139:112316
Cellular signalling 2026 Mar;139:112316
Integrated multi-omics analysis and functional validation reveal the role of TRIM2 as a potential novel biomarker in breast cancer.
Deng R, Ren Y, Hu K, Zhang Y, Xu Y, Zhang Q, Li Y, Huang X, Zhang F
Breast cancer research : BCR 2026 Mar 31;28(1)
Breast cancer research : BCR 2026 Mar 31;28(1)
TRIM2 promotes metabolic adaptation to glutamine deprivation via enhancement of CPT1A activity.
Liao K, Liu K, Wang Z, Zhao K, Mei Y
The FEBS journal 2025 Jan;292(2):275-293
The FEBS journal 2025 Jan;292(2):275-293
TRIM2 inhibits apoptosis by ubiquitinating BNIP3 to protect the intestine against ischemia-reperfusion injury in mice.
Nie J, Mei C, Wei A, Wang Y, Fan C, Huang Y, Jiang M, Che H, Chen T, Tian J, Li Y, Huang X, Zhang X
Communications biology 2025 Aug 29;8(1):1308
Communications biology 2025 Aug 29;8(1):1308
E3 ubiquitin ligase TRIM2 identified as a novel suppressor of CYP11B2 and aldosterone production.
Chen L, Hu X, Wang G, Yu F, Dai Z, Jian X, Li Y, Xiang W, Meng Z
Cellular and molecular life sciences : CMLS 2024 Dec 27;82(1):27
Cellular and molecular life sciences : CMLS 2024 Dec 27;82(1):27
Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis.
Zhou Z, Shu Y, Bao H, Han S, Liu Z, Zhao N, Yuan W, Jian C, Shu X
Journal of translational medicine 2022 Jun 7;20(1):262
Journal of translational medicine 2022 Jun 7;20(1):262
Divergent self-association properties of paralogous proteins TRIM2 and TRIM3 regulate their E3 ligase activity.
Esposito D, Dudley-Fraser J, Garza-Garcia A, Rittinger K
Nature communications 2022 Dec 8;13(1):7583
Nature communications 2022 Dec 8;13(1):7583
TRIM2 directly deubiquitinates and stabilizes Snail1 protein, mediating proliferation and metastasis of lung adenocarcinoma.
Lin Z, Lin X, Zhu L, Huang J, Huang Y
Cancer cell international 2020;20:228
Cancer cell international 2020;20:228
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- mouse small intestine tissue were subjected to SDS PAGE followed by western blot with 20356-1-AP(TRIM2 antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunofluorescent analysis of Hela cells, using TRIM2 antibody 20356-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line